AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC

Go back to AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC
Amgen Inc (NASDAQ: AMGN) Delayed: 439.38 -0.96 (0.22%)
Previous Close $440.34    52 Week High $176.85 
Open $433.08    52 Week Low $133.64 
Day High $439.40    P/E 66.17 
Day Low $431.01    EPS $6.64 
Volume 420,947